Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue:
› New product information for Hormone Replacement Therapy
› Epoetin alfa (Eprex): reports of pure red cell aplasia
› Fibrotic reactions with pergolide and other ergot-derived dopamine receptor agonists
› Olanzapine (Zyprexa) and diabetes
› Reminder: Fluoroquinolone antibiotics and tendon disorders
› Topiramate (Topamax): acute myopia and raised intraocular pressure
› Aspirin and Reye's syndrome in children up to and including 15 years of age
› Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and gastrointestinal (GI) safety
› Reminder: Use of Traditional Chines Medicines and herbal remedies
› Kava-kava and hepatotoxicity
› Clarification: Propofol (Diprivan) infusion contraindication
› Distribution of 'Current Problems in Pharmacovigilance'
Current Problems in Pharmacovigilance April 2002 
